supported by the EACR, AACR and The Mark Foundation for Cancer Research
We are awarding a number of travel grants to help EACR or AACR members to attend the 36th Pezcoller Symposium and present their work as an oral or poster presentation.
Each travel grant includes funds to support travel and accommodation costs, and reimbursement of successful applicants' registration fees. Please note that, as per the Pezcoller Symposium policy, all applicants must pay their registration fee upfront and refunds are not available. Unsuccessful travel grant applicants will therefore not receive a refund of their registration fee if they can no longer attend. Please also note that only one abstract per laboratory/research group will be accepted for presentation at the symposium.
All applications will be evaluated fully. Travel grants will be awarded based on the quality of the submitted abstract, the necessity of financial support, overall cost and affordability, geographic spread, and potential research advancement through symposium attendance.
Applicants can expect to hear the result of evaluation by 09 May 2025.
Please note that, as per the Pezcoller Symposium policy, all applicants must pay their registration fee upfront and refunds are not available. Unsuccessful travel grant applicants will therefore not receive a refund of their registration fee if they can no longer attend. Please also note that only one abstract per laboratory/research group will be accepted for presentation at the symposium.
Advances in digital technologies, including in artificial intelligence, are transforming both basic cancer research and clinical cancer medicine. The immense opportunities created by these technologies also create significant challenges, including prosaic problems such as false positives from failure to correct for multiple hypothesis testing, overfitting, and AI “hallucinations”, to challenges related to energy and infrastructure demands for data storage, ethical and equitable data access, and maintenance of workforce and lay scientific literacy and proficiency in this rapidly changing scientific environment. Topics to be included in this symposium include use of large (“big”) data and AI in basic cancer biology, cancer target selection, drug development, pathology, and radiology.
The EACR, AACR and The Mark Foundation for Cancer Research are also offering awards of €500 to the authors of the best abstracts submitted by EACR or AACR members who work in non-Italian Institutions.